Male osteoporosis: a deep dive

Male osteoporosis is a condition causing weakened, fragile bones in men, increasing fracture risk, and while less commonly discussed than in women, it's a significant health concern, particularly in older men. It often has an identifiable underlying cause more frequently than in women, making thorough investigation particularly important.

Causes include low testosterone, excessive alcohol use, smoking, certain medications (particularly long-term steroid use), chronic conditions affecting nutrient absorption, and, importantly, a specific underlying cause is identified in a higher proportion of men than women with osteoporosis. Thorough investigation to identify any treatable underlying cause is an important part of management.

Osteoporosis itself often causes no symptoms until a fracture occurs, commonly affecting the spine, hip or wrist, sometimes from relatively minor trauma. Loss of height or a stooped posture can indicate previous unrecognised spinal fractures.

Yes, fractures resulting from osteoporosis, particularly hip fractures, carry significant risk of complications and reduced mobility and independence, especially in older men. Early diagnosis and appropriate treatment can significantly reduce future fracture risk.

There's a genetic component to bone density generally, and having a family history of osteoporosis or fractures increases individual risk. However, in men, identifiable acquired causes such as low testosterone or medication effects are found more often than in women, so investigation for these specific causes is particularly important.

Yes, treatment includes addressing any identified underlying cause, such as testosterone replacement for confirmed low testosterone, alongside bone-strengthening medications, calcium and vitamin D optimisation, and weight-bearing exercise. Most men see significant improvement in bone density and reduced fracture risk with appropriate treatment.

Diagnosis typically involves a bone density scan (DEXA), alongside blood tests to check for underlying causes such as low testosterone, vitamin D deficiency, or other relevant conditions. This thorough work-up is particularly emphasised in men given the higher likelihood of an identifiable underlying cause.

Treatment includes bone-strengthening medications similar to those used in women, alongside specific treatment of any identified underlying cause, such as testosterone replacement for confirmed low testosterone. Lifestyle measures including weight-bearing exercise, adequate calcium and vitamin D, reducing alcohol intake, and stopping smoking are also important.

Osteoporosis in men is diagnosed and treated using broadly similar principles to women, but an identifiable underlying cause, such as low testosterone or medication effects, is found more frequently in men, making thorough investigation for secondary causes particularly important. Awareness of osteoporosis risk in men is also generally lower, sometimes leading to later diagnosis compared to women.

A fracture from minor trauma, or known risk factors for osteoporosis, should prompt bone health assessment. Private endocrinology or rheumatology consultations can typically be arranged within about two weeks, considerably faster than standard NHS waiting times.